Growth Metrics

Innoviva (INVA) Total Current Liabilities (2010 - 2026)

Innoviva posted quarterly Total Current Liabilities of $36.6 million for Q1 2026, down 84.43% year-on-year from $234.7 million in Q1 2025, and down 26.44% on a QoQ basis from $49.7 million in Q4 2025.

Innoviva (INVA) has 17 years of Total Current Liabilities data on file, last reported at $36.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities fell 84.43% year-over-year to $36.6 million; the trailing twelve-month figure through Mar 2026 stood at $36.6 million (down 84.43% YoY), and the FY2025 full-year result was $49.7 million, down 78.95% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $36.6 million, down from $49.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $246.6 million in Q2 2025 and bottomed at $7.0 million in Q3 2022.
  • The 5-year median for Total Current Liabilities is $49.7 million (2025), against an average of $96.1 million.
  • The widest annual swing landed in 2022, when Total Current Liabilities jumped 2771.37%; it then slumped 84.43% in 2026.
  • A 5-year view of Total Current Liabilities shows it stood at $135.0 million in 2022, then plunged by 71.75% to $38.1 million in 2023, then jumped by 519.09% to $236.1 million in 2024, then tumbled by 78.95% to $49.7 million in 2025, then slipped by 26.44% to $36.6 million in 2026.
  • The last three Total Current Liabilities figures came in at $36.6 million (Q1 2026), $49.7 million (Q4 2025), and $140.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.70 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 636.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 66.94 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 13.42 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 3.88 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 5.11 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.35 Bn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn 36.56 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 36.56 Mn
Dec 31, 2025 49.70 Mn
Sep 30, 2025 139.95 Mn
Jun 30, 2025 246.56 Mn
Mar 31, 2025 234.75 Mn
Dec 31, 2024 236.08 Mn
Sep 30, 2024 118.20 Mn
Jun 30, 2024 28.21 Mn
Mar 31, 2024 29.88 Mn
Dec 31, 2023 38.13 Mn
Sep 30, 2023 21.88 Mn
Jun 30, 2023 39.40 Mn
Mar 31, 2023 38.14 Mn
Dec 31, 2022 134.97 Mn
Sep 30, 2022 7.00 Mn
Jun 30, 2022 125.91 Mn
Mar 31, 2022 109.23 Mn
Dec 31, 2021 5.81 Mn
Sep 30, 2021 5.25 Mn
Jun 30, 2021 5.37 Mn
Mar 31, 2021 3.80 Mn
Dec 31, 2020 6.11 Mn
Sep 30, 2020 7.07 Mn
Jun 30, 2020 5.41 Mn
Mar 31, 2020 2.80 Mn
Dec 31, 2019 5.37 Mn
Sep 30, 2019 3.33 Mn
Jun 30, 2019 7.48 Mn
Mar 31, 2019 3.81 Mn
Dec 31, 2018 5.70 Mn
Sep 30, 2018 4.30 Mn
Jun 30, 2018 6.78 Mn
Mar 31, 2018 4.07 Mn
Dec 31, 2017 34.74 Mn
Sep 30, 2017 32.88 Mn
Jun 30, 2017 27.11 Mn
Mar 31, 2017 20.47 Mn
Dec 31, 2016 20.05 Mn
Sep 30, 2016 14.92 Mn
Jun 30, 2016 14.63 Mn
Mar 31, 2016 10.62 Mn
Dec 31, 2015 13.49 Mn
Sep 30, 2015 11.28 Mn
Jun 30, 2015 12.21 Mn
Mar 31, 2015 10.98 Mn
Dec 31, 2014 13.76 Mn
Sep 30, 2014 36.10 Mn
Jun 30, 2014 49.99 Mn
Mar 31, 2014 44.14 Mn
Dec 31, 2013 84.40 Mn
Sep 30, 2013 38.66 Mn
Jun 30, 2013 38.65 Mn
Mar 31, 2013 29.46 Mn
Dec 31, 2012 29.97 Mn
Sep 30, 2012 27.09 Mn
Jun 30, 2012 25.78 Mn
Mar 31, 2012 25.58 Mn
Dec 31, 2011 45.50 Mn
Sep 30, 2011 39.81 Mn
Jun 30, 2011 35.19 Mn
Dec 31, 2010 40.05 Mn